To Determine the Immune Check Point Protein Expression CTLA-4 and VISTA With Clinical and Pathological Staging of Potential Oral Malignant Lesions by Immunohistochemistry Analysis
CTLA 4 expression could serve as a helpful indicator for determining the risk of malignant transformation in oral potentially malignant disorders.
Authors
- Kalaiselvi Santhosh (ORCID: https://orcid.org/0009-0002-7853-6342)
- Santhosh Kumar
- Karthik Sigamani
- Shakila Ramalingam
- Aravindh Swamy (ORCID: https://orcid.org/0000-0002-7298-8455)
- Saravanan Thalaimalai
Institutions
- Tamil Nadu Dr. M.G.R. Medical University (IN)
Publication Details
- Journal
- Asian Pacific Journal of Cancer Prevention
- Published
- 2025-09-01
- DOI
- https://doi.org/10.31557/apjcp.2025.26.9.3439
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05